Josh Hawley Confronts 23andMe CEO Over Genetic Data Sales

Allegations of Deception Regarding User Data

• 🎯 Senator Josh Hawley accused 23andMe CEO Joe Selsavage of blatant deception concerning the handling of user genetic data.
• ⚠️ Hawley cited 23andMe's privacy policy, which he claims states the company will retain genetic information even if a customer deletes their account.
• 🤥 The Senator directly challenged Selsavage's assertion that customers have complete control over their data, presenting it as contradictory to the company's stated policies.

Business Model and Data Handling

• 📊 23andMe has approximately 14 to 15 million customers, a significant portion of whom may be minors.
• 🧬 The company collects sensitive genetic information from customers for testing purposes.
• 💰 Hawley expressed concern that 23andMe intends to sell this genetic data on the open market, potentially to large pharmaceutical companies like Regeneron.

Consent and Data Deletion Issues

• 🚫 Hawley argued that 23andMe's actions violate their privacy commitment, which states data will not be shared without customer consent.
• 📉 The Senator highlighted that 23andMe's website experienced an outage in its data deletion feature shortly after the announcement of the sale, preventing customers from exercising their right to remove their information.
• ⏳ While Selsavage stated data deletion is automatic and quick, Hawley pointed to policies indicating data could be retained for up to 30 days, contradicting claims of immediate and permanent deletion.

Contradictions and Legal Implications

• 📜 Hawley repeatedly contrasted Selsavage's testimony with the company's own privacy policy, accusing the CEO of lying.
• ⚖️ The Senator suggested that 23andMe's practices could lead to lawsuits from customers for deceptive practices and profiting from personal data.
• ⚠️ Beyond customer privacy, Hawley raised concerns about national security implications arising from the handling and potential sale of such sensitive personal information.